Our History
Servier
Servier has a 65-year history of helping provide innovative medicines to patients globally.
In the United States, Servier intends to uphold and build upon that history. Servier Group was founded by Jacques Servier in Orleans, France in 1954. A year later, the pharmaceutical company launched its first two treatments to help patients. Over the past 65 years, Servier Group has continued to expand through manufacturing, research and development, and partnerships across various global markets. Learn more about Servier’s history.
Servier Pharmaceuticals opened its United States headquarters in February 2018 and moved to Boston’s Seaport District in January 2019. We are an independent and privately held United States company focused on Oncology. Launched by Servier Group, a global organization governed by a non-profit foundation, Servier Pharmaceuticals strives to build a portfolio of innovative medicines that brings life-saving treatments to over 100 million patients around the world.
In the United States, Servier Pharmaceuticals aims to explore a broad spectrum of therapeutic innovation – from the earliest research stages through commercialization. Currently, Servier Pharmaceuticals has multiple oncology products on the market, with plans to expand into other therapeutic areas of unmet medical need.
